Cited by 96Pain Mechanisms and TreatmentsNeuropeptides and Animal PhysiologyPain Management and Placebo Effect

The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.

Lateralized kappa opioid receptor signaling from the amygdala central nucleus promotes stress-induced functional pain

Open access
Nation, Kelsey M., De Felice, Milena, Hernandez, Pablo I., Dodick, David W., Neugebauer, Volker, Navratilova, Edita, Porreca, Frank·2018·Pain

Abstract

The response of diffuse noxious inhibitory controls (DNIC) is often decreased, or lost, in stress-related functional pain syndromes. Because the dynorphin/kappa opioid receptor (KOR) pathway is activated by stress, we determined its role in DNIC using a model of stress-induced functional pain. Male, Sprague-Dawley rats were primed for 7 days with systemic morphine resulting in opioid-induced hyperalgesia. Fourteen days after priming, when hyperalgesia was resolved, rats were exposed to environmental stress and DNIC was evaluated by measuring hind paw response threshold to noxious pressure (test stimulus) after capsaicin injection in the forepaw (conditioning stimulus). Morphine priming without stress did not alter DNIC. However, stress produced a loss of DNIC in morphine-primed rats in both hind paws that was abolished by systemic administration of the KOR antagonist, nor-binaltorphimine (nor-BNI). Microinjection of nor-BNI into the right, but not left, central nucleus of the amygdala (CeA) prevented the loss of DNIC in morphine-primed rats. Diffuse noxious inhibitory controls were not modulated by bilateral nor-BNI in the rostral ventromedial medulla. Stress increased dynorphin content in both the left and right CeA of primed rats, reaching significance only in the right CeA; no change was observed in the rostral ventromedial medulla or hypothalamus. Although morphine priming alone is not sufficient to influence DNIC, it establishes a state of latent sensitization that amplifies the consequences of stress. After priming, stress-induced dynorphin/KOR signaling from the right CeA inhibits DNIC in both hind paws, likely reflecting enhanced descending facilitation that masks descending inhibition. Kappa opioid receptor antagonists may provide a new therapeutic strategy for stress-related functional pain disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/j.pain.0000000000001167

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Margolis, 2017, Electrophysiological characterization of BTRX-335140, a novel selective kappa opioid receptor antagonist, in ventral tegmental area dopamine neurons in rat, Kappa Theraupeutic Conf Abstr, 4, 72

Cited by

Metadata

Authors
Nation, K. M., De Felice, M., Hernandez, P. I., Dodick, D. W., Neugebauer, V., Navratilova, E., & Porreca, F.
Affiliations
  • University of Arizona (US)
  • Department of Pharmacology, University of Arizona, Tucson, AZ, USA. Dr. De Felice is now with the School of Clinical Dentistry, University of Sheffield, Sheffield, United Kingdom
  • Mayo Clinic in Arizona (US)
  • Texas Tech University Health Sciences Center (US)
Corresponding author
Porreca, Frank
Venue
Pain
Published
2018-01-23
Volume
159
Issue
5
Pages
919-928
ISSN
  • 0304-3959 (ISSN-L)
  • 1872-6623
OpenAlex
W2801864057
Cited by
96
References
93
Citations by year
2026: 5 · 2025: 7 · 2024: 10 · 2023: 7 · 2022: 15 · 2021: 18 · 2020: 17 · 2019: 10 · 2018: 7
FWCI
8.92
Type
journal article
Language
en
Open access
Locations
  • Pain (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Heart, Lung, and Blood Institute (R25HL108837)
  • National Institute on Drug Abuse (R01DA041809)
  • National Cancer Institute (P30CA023074)
  • National Institute of Neurological Disorders and Stroke (UH2NS093030, R01NS038261)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Pain Management and Placebo Effect
Keywords
kappa opioid receptor, dynorphin, diffuse noxious inhibitory control, central amygdala, opioid-induced hyperalgesia, nor-binaltorphimine, descending facilitation, descending inhibition, laterality, rostral ventromedial medulla
MeSH terms
Analgesics, Opioid, Animals, Capsaicin, Dynorphins, Hypothalamus, Male, Medulla Oblongata, Morphine, Naltrexone, Narcotic Antagonists, Pain, Stress, Physiological, Rats, Sprague-Dawley, Receptors, Opioid, kappa, Rats, Central Amygdaloid Nucleus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review